Abstract 224P
Background
Research has largely focused on the effect of prior androgen deprivation therapy on the subsequent risk of CVD in patients with metastatic prostate cancer. However, the impact of pre-existing CVD on localized prostate cancer treatments and outcomes is unknown. This study aimed to identify the associations of baseline CVD with treatment patterns and survival outcomes in localized prostate cancer.
Methods
We identified patients diagnosed with localized prostate cancer in a large Canadian province from 2004-2017 using the population-based registry. Administrative sources were linked to ascertain any diagnoses of CVD (including myocardial infarctions [MIs], congestive heart failure [CHF], cerebrovascular accidents [CVAs] and arrythmias [AR]) prior to the onset of prostate cancer. Logistic regression and Cox regression were used to determine the associations of baseline CVD with cancer treatments (receipt of surgery and radiotherapy) and overall survival (OS).
Results
A total of 23,670 patients were included. The median age was 65 years (interquartile range, 38-97 years). Of these, 16.4%, 71.1% and 12.5% patients had stage I, II and III prostate cancer, respectively. At the diagnosis of prostate cancer, 4860 (20.5%) had pre-existing CVD: 6.0% AR, 3.4% CVAs, 3.0% MIs, 1.8% CHF and 6.4% multiple CVDs. The Charlson comorbidity index (CCI) was 0, 1 and >1 in 55.3%, 25.4% and 19.3%. After adjusting for age, stage and CCI, pre-existing CVD was associated with a lower likelihood of surgery (odds ratio [OR], 0.88; 95% confidence interval [CI], 0.81-0.95; P=0.001), but not radiotherapy (OR, 0.96; 95% CI, 0.88-1.04; P=0.319). Likewise, CVD was associated with worse OS, after adjusting for measured confounding variables (Table). Table: 224P
Hazard ratio | 95% confidence interval | P-value | |
Age at diagnosis < 65 > 65 | Ref 3.55 | 3.29-3.83 | <0.001 |
Stage at diagnosis I II III | Ref 1.33 1.52 | 1.18-1.51 1.30-1.77 | <0.001 <0.001 |
Surgery No Yes | Ref 0.59 | 0.55-0.63 | <0.001 |
Radiotherapy No Yes | Ref 0.52 | 0.48-0.56 | <0.001 |
Baseline cardiovascular disease No Yes | Ref 1.97 | 1.85-2.10 | <0.001 |
Conclusions
One-fifth of patients with localized prostate cancer have pre-existing CVD, which was associated with a lower likelihood of surgery and worse OS. In the context of an aging general population, this may have implications for radiotherapy capacity planning as more patients are offered non-surgical therapies. Early cardio-oncology consultations may optimize the management of CVD and allow for better uptake of prostate cancer treatments.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
276P - Sarcopenia to predict overall survival in head and neck cancer patients receiving chemotherapy: A systematic review and meta-analysis
Presenter: Felix Kwenandar
Session: e-Poster Display Session
277P - Tegafur/uracil, platinum and cetuximab (UPEx) as first line treatment in frail patients with recurrent or metastatic head and neck squamous cell carcinoma
Presenter: Meng-che Hsieh
Session: e-Poster Display Session
278P - Serial assessment of parotid volume changes during radical chemoradiation of locally advanced head and neck cancer: Its implications in practice of adaptive radiotherapy
Presenter: Aathira T S
Session: e-Poster Display Session
279P - Clinico pathological characteristics and survival outcome in oral cavity cancer with masticator space involvement (T4b): A retrospective single institutional experience
Presenter: Abdulla Kunnummal Palathinkara
Session: e-Poster Display Session
280P - Safety and efficacy of concurrent chemoradiotherapy for head and neck cancers in younger versus older patients: Post hoc analysis of a randomized control trial
Presenter: Vanita Noronha
Session: e-Poster Display Session
281P - Prevalence of premalignant lesions and oral cancer among tobacco-using tea plantation workers of Nilgiri Hills, Tamilnadu, India
Presenter: Delfin Lovelina Francis
Session: e-Poster Display Session
282P - Filipino head and neck cancer patients and their quality of life
Presenter: Frederic Ivan Ting
Session: e-Poster Display Session
283P - Descriptive epidemiology of head and neck cancer in Niger: First results from the National Cancer Registry
Presenter: Salamatou Mamoudou Garba
Session: e-Poster Display Session
284P - Outcomes of metronomic adjuvant chemotherapy with tegafur-uracil in locally advanced head and neck squamous cell carcinoma
Presenter: Tsung-jang Yeh
Session: e-Poster Display Session
285P - Comparison of induction chemotherapy plus concurrent chemoradiotherapy and concurrent chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma: A meta-analysis
Presenter: Xu Guoqiang
Session: e-Poster Display Session